Today: 21 May 2026
Browse Category

ASX:MQG.AX 4 January 2026 - 3 March 2026

Macquarie Group share price slides again as oil shock grips markets — what MQG investors watch next

Macquarie Group share price slides again as oil shock grips markets — what MQG investors watch next

Macquarie Group shares fell 1.6% to A$196.71 in Sydney, extending losses after a 6.4% drop, as oil prices rose on Middle East supply fears. The S&P/ASX 200 closed down 1.34%, while volatility hit a three-month high. Brent crude climbed 2.2% to $79.44 a barrel amid concerns over the U.S.-Israeli conflict with Iran. Macquarie made no announcements Tuesday, leaving shares exposed to global market swings.
Macquarie stock heads into next week with AirFinance sale in focus and RBA decision looming

Macquarie stock heads into next week with AirFinance sale in focus and RBA decision looming

Macquarie Group shares closed nearly flat at A$212.18 Friday as investors weighed reports of a narrowed field of bidders for its AirFinance unit. The S&P/ASX 200 fell 0.65%, pressured by a slide in commodity stocks. Traders are watching the Reserve Bank of Australia’s policy decision due early February. Aviation Capital Group exited the AirFinance auction, with Dubai Aerospace Enterprise and others still in contention.
31 January 2026
Macquarie stock price slips into holiday week as filings flag stake shifts — here’s what matters next

Macquarie stock price slips into holiday week as filings flag stake shifts — here’s what matters next

Macquarie Group shares slipped 0.2% to A$210.41 at Friday’s close. Company filings showed Macquarie entities became a substantial holder in Beetaloo Energy, crossing the 5% mark, but fell below 5% in Pantoro Gold. Investors await Australia’s CPI data and the U.S. Fed’s decision on Jan. 28. The next ASX session follows a public holiday, narrowing reaction time to any market shocks.
Macquarie share price jumps on rate jitters — what moves MQG next week

Macquarie share price jumps on rate jitters — what moves MQG next week

Macquarie Group shares rose 2.6% to A$211.86 Friday after the bank raised fixed home loan rates by 0.25 percentage point, lifting its lowest one-year rate to 5.59%. The move followed similar increases by major Australian banks. An ASX notice showed Macquarie is no longer a substantial holder in Tabcorp Holdings. Investors await Macquarie’s operational briefing on Feb. 10.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop